Consider New Antibiotics After Treatment Failure for MRSA Skin Infections
You'll see several new antibiotics for treating gram-positive infections...tedizolid, dalbavancin, and oritavancin.
Tedizolid (Sivextro) and dalbavancin (Dalvance) are available now...and oritavancin (Orbactiv) is expected later this year.
This is progress in the "10 x '20 Initiative"... 10 new antibiotics available by 2020. Important targets are the "ESKAPE" bacteria...E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter species.